Logo image of YOU.DE

ABOUT YOU HOLDING SE (YOU.DE) Stock Fundamental Analysis

FRA:YOU - Deutsche Boerse Ag - DE000A3CNK42 - Common Stock - Currency: EUR

6.7  -0.02 (-0.3%)

Fundamental Rating

3

YOU gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 50 industry peers in the Specialty Retail industry. While YOU seems to be doing ok healthwise, there are quite some concerns on its profitability. YOU is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

YOU had negative earnings in the past year.
YOU had a positive operating cash flow in the past year.
In the past 5 years YOU always reported negative net income.
In the past 5 years YOU reported 4 times negative operating cash flow.
YOU.DE Yearly Net Income VS EBIT VS OCF VS FCFYOU.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -6.17%, YOU is doing worse than 64.00% of the companies in the same industry.
The Return On Equity of YOU (-30.63%) is worse than 76.00% of its industry peers.
Industry RankSector Rank
ROA -6.17%
ROE -30.62%
ROIC N/A
ROA(3y)-13.23%
ROA(5y)-15.76%
ROE(3y)-41.92%
ROE(5y)-62.39%
ROIC(3y)N/A
ROIC(5y)N/A
YOU.DE Yearly ROA, ROE, ROICYOU.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

YOU's Gross Margin of 43.32% is fine compared to the rest of the industry. YOU outperforms 66.00% of its industry peers.
In the last couple of years the Gross Margin of YOU has remained more or less at the same level.
YOU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 43.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5YN/A
YOU.DE Yearly Profit, Operating, Gross MarginsYOU.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 -10 20 30 40

More info and screens

5

2. Health

2.1 Basic Checks

YOU does not have a ROIC to compare to the WACC, probably because it is not profitable.
YOU has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, YOU has an improved debt to assets ratio.
YOU.DE Yearly Shares OutstandingYOU.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
YOU.DE Yearly Total Debt VS Total AssetsYOU.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.43 indicates that YOU is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.43, YOU is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
The Debt to FCF ratio of YOU is 1.67, which is an excellent value as it means it would take YOU, only 1.67 years of fcf income to pay off all of its debts.
YOU's Debt to FCF ratio of 1.67 is amongst the best of the industry. YOU outperforms 84.00% of its industry peers.
A Debt/Equity ratio of 0.44 indicates that YOU is not too dependend on debt financing.
YOU's Debt to Equity ratio of 0.44 is fine compared to the rest of the industry. YOU outperforms 62.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.67
Altman-Z 2.43
ROIC/WACCN/A
WACC6.8%
YOU.DE Yearly LT Debt VS Equity VS FCFYOU.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

YOU has a Current Ratio of 1.11. This is a normal value and indicates that YOU is financially healthy and should not expect problems in meeting its short term obligations.
YOU's Current ratio of 1.11 is on the low side compared to the rest of the industry. YOU is outperformed by 62.00% of its industry peers.
YOU has a Quick Ratio of 1.11. This is a bad value and indicates that YOU is not financially healthy enough and could expect problems in meeting its short term obligations.
YOU's Quick ratio of 0.58 is in line compared to the rest of the industry. YOU outperforms 50.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 0.58
YOU.DE Yearly Current Assets VS Current LiabilitesYOU.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 49.88% over the past year.
Looking at the last year, YOU shows a small growth in Revenue. The Revenue has grown by 2.63% in the last year.
The Revenue has been growing by 18.38% on average over the past years. This is quite good.
EPS 1Y (TTM)49.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)2.63%
Revenue growth 3Y18.38%
Revenue growth 5YN/A
Sales Q2Q%1.27%

3.2 Future

Based on estimates for the next years, YOU will show a very strong growth in Earnings Per Share. The EPS will grow by 26.41% on average per year.
The Revenue is expected to grow by 6.42% on average over the next years.
EPS Next Y31.54%
EPS Next 2Y31.39%
EPS Next 3Y26.41%
EPS Next 5YN/A
Revenue Next Year3.73%
Revenue Next 2Y6.04%
Revenue Next 3Y6.61%
Revenue Next 5Y6.42%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
YOU.DE Yearly Revenue VS EstimatesYOU.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
YOU.DE Yearly EPS VS EstimatesYOU.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

YOU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year YOU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
YOU.DE Price Earnings VS Forward Price EarningsYOU.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

YOU's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. YOU is more expensive than 68.00% of the companies in the same industry.
YOU's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 13.38
EV/EBITDA 124.85
YOU.DE Per share dataYOU.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

YOU's earnings are expected to grow with 26.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.39%
EPS Next 3Y26.41%

More info and screens

0

5. Dividend

5.1 Amount

YOU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABOUT YOU HOLDING SE

FRA:YOU (4/30/2025, 7:00:00 PM)

6.7

-0.02 (-0.3%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)01-09 2025-01-09/bmo
Earnings (Next)05-08 2025-05-08/amc
Inst Owners2.71%
Inst Owner ChangeN/A
Ins Owners7.29%
Ins Owner ChangeN/A
Market Cap1.25B
Analysts50
Price Target6.63 (-1.04%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.81%
Min EPS beat(2)-19.56%
Max EPS beat(2)59.17%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.01%
Min Revenue beat(2)-5.3%
Max Revenue beat(2)-2.73%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)8.59%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.47%
EPS NY rev (1m)0%
EPS NY rev (3m)1.15%
Revenue NQ rev (1m)-0.46%
Revenue NQ rev (3m)-0.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.64
P/FCF 13.38
P/OCF 9.72
P/B 5.2
P/tB 8.31
EV/EBITDA 124.85
EPS(TTM)-0.41
EYN/A
EPS(NY)-0.14
Fwd EYN/A
FCF(TTM)0.5
FCFY7.47%
OCF(TTM)0.69
OCFY10.29%
SpS10.55
BVpS1.29
TBVpS0.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.17%
ROE -30.62%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 43.32%
FCFM 4.75%
ROA(3y)-13.23%
ROA(5y)-15.76%
ROE(3y)-41.92%
ROE(5y)-62.39%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.74%
GM growth 5YN/A
F-Score6
Asset Turnover1.65
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 1.67
Debt/EBITDA 11.61
Cap/Depr 52%
Cap/Sales 1.79%
Interest Coverage N/A
Cash Conversion 1425.56%
Profit Quality N/A
Current Ratio 1.11
Quick Ratio 0.58
Altman-Z 2.43
F-Score6
WACC6.8%
ROIC/WACCN/A
Cap/Depr(3y)75.7%
Cap/Depr(5y)97.17%
Cap/Sales(3y)1.82%
Cap/Sales(5y)1.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y31.54%
EPS Next 2Y31.39%
EPS Next 3Y26.41%
EPS Next 5YN/A
Revenue 1Y (TTM)2.63%
Revenue growth 3Y18.38%
Revenue growth 5YN/A
Sales Q2Q%1.27%
Revenue Next Year3.73%
Revenue Next 2Y6.04%
Revenue Next 3Y6.61%
Revenue Next 5Y6.42%
EBIT growth 1Y48.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year135.25%
EBIT Next 3Y49.63%
EBIT Next 5Y32.95%
FCF growth 1Y140.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y166.72%
OCF growth 3YN/A
OCF growth 5YN/A